- Language: English
- 665 Pages
- Published: November 2013
- Region: Global
Global Medical Antimicrobial Coatings Market 2012-2016
- Published: November 2013
- Region: Global
- 53 pages
The analysts forecast the Global Medical Antimicrobial Coatings market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of hospital-acquired infection. The Global Medical Antimicrobial Coatings market has also been witnessing increasing partnership activities among vendors. However, the stringent regulation policies could pose a challenge to the growth of this market.
The report, the Global Medical Antimicrobial Coatings Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Antimicrobial Coatings market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are BASF SE, Covalon Technologies Ltd., Hydromer Inc., Royal DSM N.V, and Sono-Tek Corp.
Other vendors mentioned in the report are Biocoat Inc., Kane Biotech Inc., Nanexa AB, Specialty Coating Systems Inc., and TheraSyn Pharmaceuticals Inc.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report. SHOW LESS READ MORE >
01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
06. Market Landscape
06.1 Market Overview
06.1.1 Market Size and Forecast
06.2 Five Forces Analysis
07. Geographical Segmentation
07.1 Medical Antimicrobial Coatings Market in Americas
07.1.1 Market Size and Forecast
07.2 Medical Antimicrobial Coatings Market in EMEA
07.2.1 Market Size and Forecast
07.3 Medical Antimicrobial Coatings Market in APAC
07.3.1 Market Size and Forecast
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Key Vendors
16. Key Vendor Analysis
16.1 Hydromer Inc.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Royal DSM N.V
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT analysis
16.3 Sono-Tek Corp.
16.3.1 Business Overview
16.3.2 Business Segmentation
16.3.3 Key Information
16.3.4 SWOT Analysis
16.4 Covalon Technologies Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 BASF SE
16.5.1 Business Overview
16.5.2 Business Segmentation
16.5.3 Key Information
16.5.4 SWOT Analysis
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Medical Antimicrobial Coatings Market 2012-2016 (US$ million)
Exhibit 3: Global Medical Antimicrobial Coatings Market 2012
Exhibit 4: Global Medical Antimicrobial Coatings Market 2012 (in percent)
Exhibit 5: Medical Antimicrobial Coatings Market in Americas (US$ million)
Exhibit 6: Medical Antimicrobial Coatings Market in EMEA (US$ million)
Exhibit 7: Medical Antimicrobial Coatings Market in APAC (US$ million)
Exhibit 8: Analysis Business Segmentation of Hydromer Inc
Exhibit 9: Business Segmentation of Sono-Tek Corp.
Exhibit 10: Business Segmentation of Covalon Technologies Ltd.
Exhibit 11: Business Segmentation of BASF SE
Commenting on the report, an analyst from the team said: “Owing to the growing potential of the Global Medical Device market, many medical device manufacturers collaborate to develop high-quality antimicrobial-based medical devices. For example, BASF Future Business GmbH, a subsidiary of BASF SE, announced collaboration with Medi-Solve Coatings LLC for antimicrobial coatings of catheters and other minimally invasive medical devices. This collaboration combines Medi-Solve’s proprietary AquaCoat coating technology with BASF Future Business’ proprietary HyGentic silver-based antimicrobial additive platform. Similarly, Hydromer Inc. signed two licensing agreements for its coating technology, one with a US-based medical device company and another with a Chinese medical device company. Thus, the increase in partnership activities is expected to drive the growth of the Global Medical Antimicrobial Coatings market.”
According to the report, the increasing prevalence of hospital acquired infections is one of the major factors that drive the growth of the Global Medical Antimicrobial Coatings market. It is estimated that every year 1.7 million cases of hospital acquired infections occur in the US and 99,000 of the cases die from these infections. Hospital acquired infections spread through contaminated medical equipment such as catheters, needles, wound dressings, and other medical consumables while performing medical practices such as surgery.
Further, the report states that one of the main challenges in this market is the stringent regulation policies. The regulations in each country vary making it very complex and difficult for vendors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- BASF SE
- Covalon Technologies Ltd.
- Hydromer Inc.
- Royal DSM N.V
- Sono-Tek Corp.
- Biocoat Inc.
- Kane Biotech Inc.
- Nanexa AB
- Specialty Coating Systems Inc.
- and TheraSyn Pharmaceuticals Inc.